Fundraising Fox

NED Medical

Norwell, US · Founded 2022 · Delaware corporation

NED Medical develops CombiSphere, a Y90 radioembolization therapy made with proprietary materials offering optimized particle size, density, radiopacity, and dosimetry to treat liver cancer. The product is aimed at clinicians treating oncology patients through embolization therapy.

Founders & leadership

RYRichard Yazbeck
Richard YazbeckinExecutive
ATAndrew Thoreson
Andrew ThoresonNamed on SEC filing

Board

RM
Robert Matthew NiblackBoard director
DUDavid Uffer
David UfferBoard director
JM
James MitchellBoard director
GJ
Gregory J KapustBoard director

Reported raises · per SEC filings

Form D private placements

$8.5M disclosed across 2 rounds · 2023–2026

$8MraisedFeb 2026 · 3 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Robert Matthew NiblackDirector
  • David UfferDirector
  • James MitchellDirector
  • Richard YazbeckExecutive Officer, Director
  • Gregory J KapustDirector
Offering amount
$11M
Amount sold
$8M
First sale
Jan 2026
Incorporated
Corporation, Delaware, 2022
Federal exemptions
06b
Full filing on SEC EDGAR ↗
$500KraisedAug 2023 · 2 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Richard YazbeckDirector
  • Robert Matthew NiblackDirector
  • David UfferDirector
  • Andrew ThoresonDirector
Offering amount
$1.8M
Amount sold
$500K
First sale
Aug 2023
Incorporated
Corporation, Delaware, 2022
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Competitors · 1

by search overlap

Companies competing with NED Medical for the same Google search keywords, organic and paid, via search-intersection analysis.

In the news

Frequently asked questions

What does NED Medical do?
NED Medical develops CombiSphere, a Y90 radioembolization therapy made with proprietary materials offering optimized particle size, density, radiopacity, and dosimetry to treat liver cancer. The product is aimed at clinicians treating oncology patients through embolization therapy.
How much funding has NED Medical raised?
NED Medical has disclosed $8.5M raised across 2 rounds.
Where is NED Medical headquartered?
NED Medical is headquartered in Norwell, US.